Effect of Commiphora molmol Engler extract complex on the Mild Cognitive Impairment for the Efficacy and Safety; A 12week, Multi-center, Randomized, Double-blind, Placebo-Controlled Clinical Trial
Not Applicable
Completed
- Conditions
- Mental and behavioral disorders
- Registration Number
- KCT0002002
- Lead Sponsor
- Hanpoong Pharm & Foods
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 90
Inclusion Criteria
Subject who have decreased CERAD-K(Consortium to Establish a Registry for Alzheimer’s Disease-Korean version) memory score(-1.0SD<=CERAD-K memory score) comparing to the same age and education group.
Exclusion Criteria
Subject with mental disorders such as schizophrenia, depressive disorder, drug intoxication
Study & Design
- Study Type
- Interventional Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method ADAS-cog(Alzheimer’s Disease Assessment Scale-Korean version-cognitive subscale) Total score
- Secondary Outcome Measures
Name Time Method ADAS-cog(Alzheimer’s Disease Assessment Scale-Korean version-cognitive subscale) memory;Adverse Event